Short-bowel syndrome is used to describe a condition of malabsorption and malnutrition resulting from the loss of absorptive surface area following massive smallbowel resection. The key to survival of patients with short bowel syndrome is the ability of the residual bowel to adapt. Postresection intestinal adaptation is in¯u-enced by several factors, including luminal nutrients, hormones and peptide growth factors. Enteral feeding is one of the major factors in stimulating intestinal adaptation after bowel resection. Between luminal factors promoting intestinal adaptation, pectin, short-chain triglycerides, free fatty acids and glutamine may be helpful. There is evidence in animal and clinical studies that some hormonal manipulation (growth hormone) improves adaptive small bowel growth after massive small bowel resection. Peptide growth factors are produced by epithelium of gastrointestinal tract and are classi®ed into several discrete families on the basis of structural homologies and disparities. Many of these agents have been shown to enhance intestinal adaptation. Future clinical trials will be necessary to evaluate the roles of these growth factors in treatment of patients with short bowel syndrome. More work will be also required to resolve questions concerning how proadaptive agents may in¯uence cellular and molecular mechanisms of nutrient absorption following bowel resection.
Short-bowel syndrome (SBS) is a condition characterized by a loss of intestinal length or competence, resulting in a diminished ability to digest and absorb a regular diet [2] . Many authors de®ne a loss of 50% or more of small-bowel length as SBS [8, 47] . SBS is a common problem in pediatric surgery and a signi®cant cause of infant mortality and morbidity. Many clinical conditions in the neonate may necessitate intestinal resection; however, the most common indications are necrotizing enterocolitis, intestinal atresia, and volvulus [2, 8, 47] . Despite the availability of total parenteral nutrition (TPN) and advances in medical treatment, the morbidity of SBS remains strikingly high [9, 34] . The key to survival after massive small-bowel resection is the ability of the residual bowel to adapt. In the early twentieth century it was ®rst observed that massive small-bowel resection led to``compensatory hypertrophy'' of the remaining gut [32] . In 1957 Pilling and Cresson [35] described the ®rst successful extensive resection in two infants, who survived with only 26 and 28 cm remaining small bowel. Subsequently, many series of patients have documented survival in infants with even shorter small-bowel remnants [23, 38] .`A daptation'' is the term applied to the progressive recovery from intestinal failure following a loss of intestinal length [2] . Through the process of adaptation, the small bowel increases its absorptive surface area and its functional capacity to meet the body's metabolic and growth needs [50] . Intestinal adaptation begins within 48 h of resection, lasts for at least 18 months, and includes morphologic and functional changes of the residual bowel. Morphologic changes include lengthening of the villi, deepening of the crypts, increasing rates of enterocyte proliferation, increasing epithelial cell number per villus, and ®nally, an increase in the total number of enterocytes. Functional changes result in increasing nutrient uptake by isolated enterocytes. Several studies have shown that the functional integrity of the remaining intestine is of far more importance than the outward appearance of the bowel [9] . The enhanced intestinal absorption associated with the hyperplasia may permit compensation for the loss of proximal transport function and maintain normal growth.
Functional changes during adaptation
Research on functional adaptation following massive small-bowel resection is organized around four questions: (1) the pattern of the adaptation: does transport of dierent nutrients increase or decrease following bowel resection? (2) the mechanistic basis for the adaptation: are the changes in nutrient transport due to changes in the number of existing enterocytes or to the production of new cells with dierent transport activity? (3) the time course and reversibility of adaptation; and (4) the factors in¯uencing intestinal adaptation [24] .
Patterns of adaptation
Several experiments have demonstrated that animals with resected intestine can often achieve virtually complete nutrient absorption by increasing their transport rates per cm intestine [24] . Mucosal hypertrophy and enhanced glucose absorption were demonstrated in the intestinal remnant in rats following extensive smallbowel resection; these changes developed after 2 weeks and were greater in the ileal remnant than in the jejunum [12] . Similar studies directed at intestinal protein metabolism in animals with SBS demonstrated an increase in activity of enterokinase and peptide hydrolase and increased uptake of amino acids per cm bowel length [18] . Absorption per cm of intestine is also increased for calcium [49] and other electrolytes. Rogers and Bochenek [39] demonstrated an increase in speci®c and total activity in the ileum of lipid re-esterifying enzymes after jejunectomy in rats.
Mechanisms of functional adaptation
A major impediment to the progress of research in the area of intestinal adaptation has been a lack of understanding the cellular and molecular mechanisms of increased intestinal nutrient transport following bowel resection. A very recent advance in this area has been the development and optimization of methods for determining dierent transporter genes and cellular transport systems. Hines et al. [20] have reported an increase in ileal sodium glucose cotransporter (SGLT1) mRNA expression after bowel resection. Additional evidence that SGLT1 cotransporter is involved in adaptation comes from the experiments of Sigalet and Martin [41] .
The importance of epidermal growth factor (EGF) in intestinal adaptation is underscored by a number of recent studies in which increases in EGF receptor expression mRNA and protein have been shown in animals following bowel resection [14, 52] . Dodson et al. [11] analyzed cloned cDNA dierentially expressed in adapting remnant ileum after 70% bowel resection and showed an increase in groups of genes involved in functional response (e.g., liver fatty acid-binding Time course and reversibility of adaptation Determining the time course and reversibility of intestinal nutrient absorption and transport can be important in identifying the mechanisms of intestinal adaptation after bowel resection. Changes in intestinal transport rate that are completed in a few hours are unlikely to be mediated by gross structural changes, while a more delayed adaptive response may be related to changes in absorptive surface area and increases in total number of enterocytes [23] . The evidence for increased amino-acid transport following intestinal resection comes from experiments of Menge et al. [34] . We have recently examined a time course of food and fat intake, clearance, and absorbability in a rat model of SBS and found a decreased calculated fat and food absorption rate following massive small bowel resection [25] .
Eect of pro-adaptive factors on functional adaptation
Over the past decades, much research has focused on the identi®cation of factors stimulating bowel regrowth. Little attention was given to evaluation of the eects of pro-adaptive agents on adaptation of intestinal nutrient transport. It has been shown that hepatocyte growth factor (HGF) may enhance carbohydrate absorption by up-regulating an intestinal epithelial glucose transporter gene [25] . The importance of interleukin 11 (IL-11) on absorptive function is underscored by a recent study in which IL-11 given subcutaneously enhanced substrate absorption after bowel resection [1] . Glucagon-like peptide-2 has been shown to enhance small-intestinal absorption in vivo in a rat model of SBS [25] . Iannoli et al. [21] showed that administration of growth hormone (GH) signi®cantly increases small-bowel brushborder membrane transport amino acids following small-bowel resection. Our laboratory has recently shown that LCFA may alter CD36 mRNA intestinal expression and fatty-acid transport by isolated enterocytes in a rat model of SBS [44] . Although several lines of evidence have demonstrated the importance of speci®c nutrients and certain trophic growth factors on intestinal growth and function, more work will be required to resolve questions concerning how proadaptive agents may in¯uence cellular and molecular mechanisms of nutrient absorption following bowel resection.
Anatomic changes during adaptation
Another area about which there has been considerable debate is structural adaptation after massive smallbowel resection. A major focus of investigators in this area has been the elucidation of the molecular and cellular mechanisms underlying intestinal growth. Although traditional indices of adaptation (overall bowel and mucosal weight, mucosal DNA and protein, villus height, and crypt depth) are still relevant for intestinal growth studies, morphologic adaptation has recently been subjected to cellular and molecular analysis. The dynamic process of small-bowel turnover is a function of the rates of crypt-cell proliferation, migration along the small-bowel crypt-villus axis, and cell death via apoptosis [55] . The increase in villus height and crypt depth has been thought to be a result of cellular hyperplasia, leading to a marked increase in individual cell-surface area and overall absorption capability even though mucosal cellularity may be unaltered. There may also be a change in the enterocyte dierentiation process as a part of adaptation.
Under normal circumstances, newly-formed immature enterocytes divide in the crypts of LieberkuÈ hn and migrate to the villus tip, undergoing dierentiation and maturation, and become capable of absorbing nutrients. Little is known about the eects of dierent pro-adaptive agents on the process of enterocyte dierentiation. However, an increase in the proportion of fully-dierentiated cells increases the total enterocyte transport pool and may signi®cantly increase nutrient transport. Little data are available on the role of apoptosis, or programmed cell death, in preserving enterocyte mass following bowel resection. Apoptosis is a cascade of catabolic reactions leading to cell death by``suicide.'' This process can be initiated by dierent signaling pathways and is altered by many factors, including radiation, in¯ammation, and bowel resection [56] . Recent evidence demonstrates that apoptosis increases after bowel resection [10, 19] . However, a reduction in the rate of apoptosis might indicate adaptive mechanisms to preserve enterocyte mass.
The identi®cation of factors that promote growth and regeneration of the intestinal epithelium and reduce apoptosis will suggest new therapeutic strategies for augmenting intestinal adaptation. It has been reported that both enterocyte production and loss via apoptosis were decreased by reduced enteral intake in rats following bowel resection [10] . A major focus for investigators in this area will be to elucidate the eects of the other pro-adaptive factors on cellular proliferation and apoptosis following bowel resection.
Accelerating adaptation
The regulation of intestinal adaptation is maintained through the complex interaction of many dierent factors. These include nutrients and other luminal constituents, hormones, and peptide growth factors.
Enteral feeding
The initial management of patients with SBS involves TPN. However, it has been shown that enteral feeding is one of the major trophic factors in stimulating gut regrowth; therefore, once the patient demonstrates a stable clinical course, the postoperative ileus resolves, and the viability of the residual intestine is con®rmed, enteral feeding should be attempted. The importance of enteral nutrition in the adaptation of the small intestine after resection has been con®rmed by many studies [30, 35, 53] . However, the mechanism whereby food induces this adaptation is unknown. It is likely that enteral nutrition works through a number of mechanisms, including direct stimulatory eects on the epithelial cells themselves and stimulation of secretion of trophic hormones from the gastrointestinal (GI) tract [50] . Additionally, luminal nutrients increase pancreatobiliary secretion, gut neuronal activity, peristalsis, and splanchnic blood¯ow.
Not all nutrients have equally stimulating trophic eects. Research has recently been directed at those trophic factors that may in the future have therapeutic implications for patients with SBS. It has been suggested that pectin, short-chain triglycerides, LCFA, and glutamine have important roles as pro-adaptive agents in experimental animals with SBS [3] . The addition of pectin to enteral feeding in rats with SBS leads to a more rapid and higher adaptive response in the small and large bowel compared to control animals [27] .
The amino acid glutamine is utilized as a major fuel by intestinal cells; however, the underlying molecular mechanisms of its anabolic eect are not clearly understood [54] . Animal studies and recent investigations in humans have demonstrated that glutamine alone [55] or combined with insulin-like growth factor (IGF) [56] or GH [4] can stimulate intestinal adaptation and reduce the degree of GI atrophy associated with TPN. LCFA appear to be more eective stimulators of intestinal adaptation than either medium-chain fats (MCF) or carbohydrates [50] . Consequently, a mixture of longand MCF is recommended for patients with SBS. MCF are recommended because they are tolerated more easily, and LCFA because they are important in stimulating intestinal adaptation. It has been reported that animals with SBS receiving an essential-fatty-acid de®cient diet have signi®cantly impaired intestinal mucosal hyperplasia [18] . We have recently shown that a high-fat diet both augments and accelerates intestinal adaptation in rats following bowel resection. The resected animals fed a high-fat diet showed signs of postresection mucosal adaptation on day 3 after operation, while the rats fed normal chow demonstrated signs of complete adaptation on day 14 [45] .
Pro-adaptive hormones
There is evidence that some hormonal manipulation can improve intestinal adaptation in an animal model of SBS. The relationship between GH and events in the small intestine following bowel resection remains to be conclusively demonstrated. Earlier studies by Mainoya [32] demonstrated that GH can increase nutrient and electrolyte absorption in hypophysectomized animals. Later, Byrne et al. [5] reported that GH and dietary modi®cation improved nutrient absorption in patients with SBS. It bears emphasis that similar studies performed in animal models of SBS showed no eect of GH on intestinal adaptation [51] . The eect of GH on adaptive processes is probably mediated through IGF-1, which is produced in the liver and may increase cryptcell production, villus height, and nutrient absorptive capacity [42] .
Peptide growth factors
Several distinct peptide families have now been recognized to modulate growth in the GI tract [35] . Over the past 30 years, an increasing number of regulatory peptides produced by cellular constituents have been identi®ed, and mechanisms whereby these factors modulate cell turnover in normal intestinal homeostasis have been studied. The peptide growth factors are classi®ed into several discrete families on the basis of structural homologies and disparities [35] . They include the EGF transforming growth factor b (TGFb), IGF, and ®bro-blast growth factor (FGF) families. In addition, a smaller number of peptide growth factors without structural similarities of the described families have also been identi®ed and include HGF and platelet-derived growth factor (PDGF).
EGF was initially isolated by Cohen [7] from mouse submaxillary glands as the factor responsible for promoting premature eyelid opening in neonatal mice. Later, EGF was also identi®ed within the GI tract and was shown to regulate cell proliferation and other functions through interaction with the mucosa at the luminal surface [16, 48] . There is con¯icting evidence concerning the eect of EGF on intestinal adaptation following bowel resection. Earlier studies in rat small intestine by Chaet et al. [6] demonstrated that EGF augments intestinal adaptation in the animal models of SBS. Further experiments have shown that EGF enhances functional enterocyte adaptation after small-bowel resection [13] . It bears emphasis that similar studies performed by Lukish et al. [31] in rats with SBS showed no eect of EGF on microscopic and ultrastructural features of the rat small-intestinal mucosa following massive small-bowel resection.
The second member of the EGF family, TGFa, is a 50-amino-acid polypeptide that appears to act through the same receptor as EGF. TGFa has been demonstrated to directly promote cell proliferation and to exert a trophic eect on intact gastric, intestinal, and colonic mucosa [37] . Recently, TGFa has been shown to stimulate intestinal-cell proliferation via activation of EGF receptors in a rat model of SBS [15] . The role of the other EGF family members (amphiregulin, heparinbinding EGF, pox-virus growth factor, cripto, and heregulin) have not been examined for their role during intestinal adaptation, and future studies will be needed to evaluate these alternative EGF ligands during the adaptive response.
The IGF family includes three peptides: insulin, IGF-I, and IGF-II. The evidence that both IGF I and II are involved in modulation of growth and dierentiation of normal small bowel comes from experiments by Laburthe et al. [28] , who have shown that infusion of IGF I into rodent ileum resulted in a twofold increase in mucosal weight and other parameters of bowel growth. As alluded to above, IGF1 is produced in the liver in response to GH, and may stimulate cell proliferation and increase villus height and nutrient absorptive capacity in an animal model of SBS [42] . Additional evidence that IGFI is involved in intestinal adaptation comes from experiments by Ziegler et al. [54] , who showed that in rats with SBS ileal IGF-I mRNA expression rose nearly twofold during intestinal adaptation after bowel resection, which was augmented by IGF-I administration. Lukish et al. [31] have demonstrated that EGF and IGF1 increase substrate absorption after small-bowel resection in rats, and this increase in absorption persists after cessation of administration of these growth factors.
HGF is a distinctive growth-modulating peptide that has been identi®ed in primary hepatocytes and is also expressed in stomach, small intestine, and colon [46] . After reviewing the evidence for the role of HGF as a pro-adapting agent after bowel resection, it should be mentioned that recent work by Kato et al. [26] has demonstrated a dramatic response in mucosal mass and enterocyte functional capacity following bowel resection in rats exposed to HGF. Other investigations have shown that HGF upregulates intestine epithelial glucose transporter gene expression, which is responsible for enhanced carbohydrate absorption in rats with SBS after HGF administration [24] .
The eects of other peptide growth factors (FGF family, TGFb family, and PDGF) on bowel growth have been examined in normal intestine, but have not been evaluated in an animal model of SBS. Future experiments will, therefore, be needed to examine the role of these factors and to elucidate the potential mechanisms by which they aect the adaptive response.
Future directions
Despite enormous advances in our understanding of the cellular and molecular mechanisms of intestinal adaptation following massive small-bowel resection over the last decades, more questions have been raised than answered. Research on intestinal adaptation following massive small-bowel resection should address the following areas:
1. Detailed understanding of the mechanisms by which intestinal adaptation is stimulated is still lacking, and this may have important clinical implications. Further work is needed to de®ne the full spectrum of factors that play a role in regulating growth in the GI tract and to elucidate the mechanisms through which they may aect bowel growth and nutrient absorption following bowel resection. 2. Understanding the pathophysiology of the augmented absorptive and digestive capacity of the remaining bowel is essential in the development of useful management strategies for patients with SBS. An important area of research will be to understand the basis of the role of dierent intracellular transport proteins on nutrient absorption. Further studies of enterocyte gene regulation and protein expression will be needed to determine the molecular and cellular mechanisms responsible for the enhancement of substrate absorption by several pro-adaptive factors beyond that that occurs with intestinal adaptation. 3. Further studies that de®ne mechanisms of cell proliferation and apoptosis will be important to increase understanding of the regulation of intestinal adaptation. The identi®cation of new factors that can promote intestinal cell proliferation and reduce apopto sis will suggest new therapeutic strategies in the treatment of patients with SBS. 4. Evidence thus far indicates that general nutritional status, speci®c nutrients, intestinal hormones, and peptide growth factors have important interactions that are necessary for stimulation of intestinal adaptation. Although the underlying mechanisms of these synergistic responses are unclear, intestinal adaptation after bowel resection may be facilitated by provision of both an appropriate nutrient background and exogenous gut-trophic hormones. Additional studies that determine basic mechanisms of nutrientgrowth factor interactions and the clinical ecacy of combinations of dierent pro-adaptive factors may be useful for de®ning new therapies in patients with SBS. 5. Finally, much is still to be learned about the ability of pro-adaptive factors to enhance intestinal adaptation in humans. Although several animal studies have identi®ed a variety of factors promoting intestinal adaptation, only a few clinical trials have focused on the eect of these factors on intestinal growth in humans. The eects of GH, glutamine, and diet modi®cation have been examined in the treatment of patients with SBS [54] . Future experiments should be directed at evaluating the eects of other agents on intestinal adaptation in the clinical setting.
